Oh PI - Search Results

1

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

Lanctôt KL, Best TS, Mittmann N, Liu BA, Oh PI, Einarson TR, Naranjo CA. Lanctôt KL, et al. Among authors: oh pi. J Clin Psychiatry. 1998 Oct;59(10):550-61; quiz 562-3. doi: 10.4088/jcp.v59n1010. J Clin Psychiatry. 1998. PMID: 9818639

2

A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children.

Oh PI, Maerov P, Pritchard D, Knowles SR, Einarson TR, Shear NH. Oh PI, et al. Clin Ther. 1996 Jan-Feb;18(1):160-82. doi: 10.1016/s0149-2918(96)80188-3. Clin Ther. 1996. PMID: 8851461

3

Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.

Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR. Oh PI, et al. Can J Clin Pharmacol. 2001 Winter;8(4):199-206. Can J Clin Pharmacol. 2001. PMID: 11743592

4

Utility scores of symptom profiles in major depression.

Schaffer A, Levitt AJ, Hershkop SK, Oh P, MacDonald C, Lanctot K. Schaffer A, et al. Psychiatry Res. 2002 Jun 1;110(2):189-97. doi: 10.1016/s0165-1781(02)00097-5. Psychiatry Res. 2002. PMID: 12057830

5

Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.

Oh PI, Lanctôt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators. Oh PI, et al. Pediatr Infect Dis J. 2002 Jun;21(6):512-8. doi: 10.1097/00006454-200206000-00007. Pediatr Infect Dis J. 2002. PMID: 12182374 Clinical Trial.

6

The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.

Wu G, Lanctôt KL, Herrmann N, Moosa S, Oh PI. Wu G, et al. Among authors: oh pi. CNS Drugs. 2003;17(14):1045-57. doi: 10.2165/00023210-200317140-00004. CNS Drugs. 2003. PMID: 14594444

7

Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomes.

Mittmann N, Oh PI, Walker SE, Bartle WR. Mittmann N, et al. Among authors: oh pi. Pharmacoeconomics. 2004;22(10):671-83. doi: 10.2165/00019053-200422100-00005. Pharmacoeconomics. 2004. PMID: 15244492

8

The economics of adjunctive therapies in coronary angioplasty: drugs, devices, or both?

Oh PI, Cohen EA, Mittmann N, Seung SJ. Oh PI, et al. Can J Clin Pharmacol. 2004 Fall;11(2):e202-11. Epub 2004 Sep 14. Can J Clin Pharmacol. 2004. PMID: 15520474

9

Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease.

Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctôt KL. Swardfager W, et al. J Rehabil Med. 2008 Mar;40(3):213-8. doi: 10.2340/16501977-0151. J Rehabil Med. 2008. PMID: 18292924 Free article.

10

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis.

Lanctôt KL, Masoud ST, Paes BA, Tarride JE, Chiu A, Hui C, Francis PL, Oh PI. Lanctôt KL, et al. Among authors: oh pi. Curr Med Res Opin. 2008 Nov;24(11):3223-37. doi: 10.1185/03007990802484234. Epub 2008 Oct 16. Curr Med Res Opin. 2008. PMID: 18928643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters